This issue focuses on Obstetric APS (OAPS), an APS variant affecting pregnancy at various stages and increasingly recognized as separate from its thrombotic counterpart.
Antiphospholipid Syndrome is a rare disease, more frequently diagnosed in women than in men. In the United States, the estimated annual prevalence of OAPS is around 4 cases per 100,000 individuals, with rates rising to 13 per 100,000 among women aged 30 to 39. If left untreated, fetal loss may occur in 30-80% of the pregnancies.

Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. 
We hope you join this effort!

This episode includes AI-generated content.

This episode focuses on Catheter-Related Thrombosis (CRT), a condition accounting for most upper extremity DVTs and approximately 10% of all VTEs. However, with the increasing use of peripherally inserted central catheters, the incidence of CRT is expected to rise further.

Central venous catheters (CVCs) are indispensable in modern medicine, especially for patients needing long-term intravenous therapy, chemotherapy, hemodialysis, or parenteral nutrition. Despite their benefits, CVCs can lead to several complications, with CRT being one of the most significant.









Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. 
We hope you join this effort!

This episode includes AI-generated content.

This episode focuses on Antiphospholipid Syndrome (APS), a complex condition affecting about 2% of the population, predominantly women of childbearing age.

APS is a systemic autoimmune disease characterized by recurrent thrombotic events in arteries, veins, or small vessels and/or spontaneous early miscarriages with maternal morbidity, caused by persistent antiphospholipid antibodies (aPL).

The precise mechanisms by which aPLs lead to thrombosis are not fully understood. It is believed that these antibodies interfere with the normal function of phospholipids in the blood, essential for coagulation, leading to an increased risk of blood clot formation.









Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. 
We hope you join this effort!

This episode includes AI-generated content.

In this episode, we focus on May-Thurner Syndrome, a relatively underdiagnosed condition that typically affects adults aged 20 to 50. Bringing attention to this syndrome is crucial, as DVT is often mistakenly seen as primarily affecting the elderly.
May-Thurner Syndrome (MTS), also known as iliac vein compression syndrome or Cockett's syndrome, occurs when the right iliac artery compresses the left iliac vein, restricting blood flow and causing it to pool in the leg. This compression disrupts normal blood flow, leading to various complications, including DVT. 
While the prevalence of the disorder is unknown, this condition is found in 2–5% of patients undergoing evaluation for lower extremity venous disorders and often affects young women. 








Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. 
We hope you join this effort!

This episode includes AI-generated content.

In this episode, we explore upper extremity deep vein thrombosis (UEDVT), a less common type of thrombosis characterized by blood clots forming in the deep veins of the arms, shoulders, or neck. Despite being less prevalent than lower extremity DVT, UEDVT presents notable health risks and warrants significant attention.

Etiology and Epidemiology

UEDVT can arise from various factors. A common cause is the use of medical devices such as central venous catheters, pacemakers, or defibrillators, which can irritate or damage vein walls. Cancer and its treatments, particularly chemotherapy, can also elevate the risk. Additionally, repetitive arm movements, often seen in athletes, can result in Paget-Schroetter syndrome, a relatively rare type of UEDVT also known as “effort thrombosis”.
Nowadays, UEDVT accounts for 5% to 10% of all DVT cases, with incidence rates increasing annually. Most patients with UEDVT have a central line, with an incidence rate between 14% and 23%. Pulmonary embolism (PE) occurs in up to 6% of the cases.









Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. 
We hope you join this effort!

This episode includes AI-generated content.

VTE is a leading cause of death and disability worldwide, affecting individuals of all ages, genders, and ethnicities. Often asymptomatic, misdiagnosed, and unrecognized at death, VTE poses a significant challenge for HCPs due to its insidiousness.

Identifying and Managing Risk Factors

Key VTE risk factors include immobility, surgery, specific medical conditions, lifestyle choices, and family history. Recognizing at-risk patients is the first step in preventing thrombosis. HCPs should educate each patient on preventing clot formation and prescribe mechanical prophylaxis and anticoagulants for High-risk individuals.









Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. 
We hope you join this effort!

This episode includes AI-generated content.

“Thrombophilia”, from the Greek words “trombo” (blood clot) and “philia” (affinity), indicates an increased tendency to form pathological intravascular thrombosis, which may develop spontaneously or at a young age. Screening is typically limited to high-risk individuals rather than the general population.
In the early 1980s, both Protein C and Protein S deficiencies were identified in the United States. These autosomal dominant conditions increase thrombosis risk 5- to 10-fold in heterozygotes, while homozygosity is often fatal without treatment. In 1994, Prof. Bertina and his team discovered FV Leiden. This mutation, converting arginine 506 to glutamine, makes FV resistant to inactivation by activated protein C, significantly raising VTE risk, and is observed in 1 to 5% of the general population, which represents 30 to 50% of all congenital thrombophilia cases.








Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. 
We hope you join this effort!

This episode includes AI-generated content.

The history of thrombosis is intertwined with the evolution of medicine, which was once closely linked to philosophy.  
Aristotle made significant observations on blood coagulation, attributing it to the presence of fibrous material in the blood. Galen, a prominent Roman physician whose theories influenced Western medicine for over a millennium, was the first to introduce the term “thrombosis”, derived from the Greek word for curdling. 
Since then, thrombosis knowledge has evolved.

Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. 
We hope you join this effort!

This episode includes AI-generated content.

Thrombosis: A Silent Killer

Thrombosis, the formation of a blood clot within a blood vessel, is a serious health condition that often goes unnoticed until it's too late. This silent killer can lead to devastating complications, including heart attacks, strokes, and pulmonary embolisms. 






Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content. 
We hope you join this effort!

This episode includes AI-generated content.